Combizole Oral Suspension

Ország: Írország

Nyelv: angol

Forrás: HPRA (Health Products Regulatory Authority)

Aktív összetevők:

Fenbendazole; Levamisole hydrochloride

Beszerezhető a:

Cross Vetpharm Group Limited

ATC-kód:

QP52A

INN (nemzetközi neve):

Fenbendazole; Levamisole hydrochloride

Adagolás:

25.0/37.5 milligram(s)/millilitre

Gyógyszerészeti forma:

Oral suspension

Recept típusa:

LM: Licensed Merchant as defined in relevant national legislation

Terápiás csoport:

Sheep

Terápiás terület:

ANTHELMINTICS

Terápiás javallatok:

Endoparasiticide

Engedélyezési státusz:

Authorised

Engedély dátuma:

2005-02-04

Termékjellemzők

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Combizole Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
An aqueous milky white free flowing suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of roundworm, lungworm and tapeworm infections of
sheep caused by:
Gastrointestinal Roundworms:_ Bunostomum, Chabertia, Cooperia,
Haemonchus, Nematodirus, Oesophagostomum,_
_Ostertagia, Trichostrongylus_
Lungworms:
_Dictyocaulus_
Tapeworm:
_Moniezia_ spp
The product is active against mature and immature parasite stages
sensitive to fenbendazole or levamisole.
Fenbendazole is ovicidal and will kill worm eggs.
4.3 CONTRAINDICATIONS
Do not use in animals that are severely stressed or in ill-health.
Each ml contains:
ACTIVE SUBSTANCES:
Levamisole Hydrochloride 37.5 mg
Fenbendazole
25.0 mg
EXCIPIENTS
Formaldehyde Solution
2.0
mg
Potassium Sorbate
1.8
mg
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_7_
_0_
_0_
_6_
_7_
_0_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not administer to sheep under stress or in poor condition.
Care should be taken to avoid the following practices because they
increase the risk of development of resistance and
could ultimately result in ineffective therapy.
- Too frequen